ID: ALA5191647

Max Phase: Preclinical

Molecular Formula: C24H21N3O3

Molecular Weight: 399.45

Associated Items:

Representations

Canonical SMILES:  CN1C(=O)C(C/C=N/n2c3ccccc3c3ccccc32)COC12C=CC(=O)C=C2

Standard InChI:  InChI=1S/C24H21N3O3/c1-26-23(29)17(16-30-24(26)13-10-18(28)11-14-24)12-15-25-27-21-8-4-2-6-19(21)20-7-3-5-9-22(20)27/h2-11,13-15,17H,12,16H2,1H3/b25-15+

Standard InChI Key:  UINTVEZGASXCJW-MFKUBSTISA-N

Associated Targets(Human)

N-lysine methyltransferase SMYD2 395 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ca-Ski 420 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 399.45Molecular Weight (Monoisotopic): 399.1583AlogP: 3.51#Rotatable Bonds: 3
Polar Surface Area: 63.90Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.25CX LogP: 3.12CX LogD: 2.21
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.63Np Likeness Score: 0.28

References

1. Dhorma LP, Teli MK, Nangunuri BG, Venkanna A, Ragam R, Maturi A, Mirzaei A, Vo DK, Maeng HJ, Kim MH..  (2022)  Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space.,  227  [PMID:34656041] [10.1016/j.ejmech.2021.113880]

Source